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Brain ischemia and reperfusion is the leading cause of serious and long-range disability in
the world. Clinically signiﬁcant changes in central nervous system function are observed
following brain ischemia and reperfusion. Stroke patients exhibit behavioral, cognitive,
emotional, affective and electrophysiological changes during recovery phase. Brain injury
by transient complete global brain ischemia or by transient incomplete brain ischemia
afﬂicts a very large number of patients in the world with death or permanent disability. In
order to reduce this damage, we must sufﬁciently understand the mechanisms involved in
brain ischemia and reperfusion and repair to design clinically effective therapy.
Cerebral ischemia and reperfusion is known to induce the generation of reactive oxygen
species that can lead to oxidative damage of proteins, membrane lipids and nucleic acids.
A decrease in tissue antioxidant capacity, an increase in lipid peroxidation as well as an
increase in lipid peroxidation inhibitors have been demonstrated in several models of
brain ischemia. This paper reviews the number of commonly used types of herbal
medicines effective for the treatment of stroke. The aim of this paper was to review
evidences from controlled studies in order to discuss whether herbal medicine can be
helpful in the treatment of brain ischemia and reperfusion.1. Introduction
Stroke is the leading cause of serious, long-range disability
with about 600000 people suffering stroke each year [1]. Stroke
survivors may develop difﬁculties with memory, thinking,
talking, partial paralysis, and mobility problems. In the Western
world, over 70% of stroke survivors are over age 65. Since life
expectancy continues to grow, the number of stroke survivors
will further increase in the future [2]. Three months after stroke,
15%–30% of patients will be permanently disabled and 20%
require institutional care [2]. Brain injury by transient complete
global brain ischemia and regional incomplete brain ischemia
afﬂicts a very large number of patients with death or permanent
disability [1]. Stroke is the rapid progress of clinical signs of
focal and global disturbance of cerebral function, with
symptoms that can last more than 24 h or lead to death, with
no apparent cause other than vascular origin [3]. The only drugthat is used for the thrombolytic treatment of acute ischemic
stroke in the US is intravenous recombinant tissue plasminogen
activator (rt-PA). When delivered within 3 h after symptom
onset, rt-PA reduces neurological damages and improves the
functional outcome of stroke survivors. This improvement in re-
covery is achieved at the expense of an increased incidence in
symptomatic intracranial hemorrhage, which occurs in ~6% of
survivors. However, a large number of patients with acute
ischemic stroke do not go to the hospital within the ﬁrst hours
after brain ischemia onset, so most of these patients do not receive
rt-PA treatment [4].
2. Brain ischemia and reperfusion pathogenesis
In brain ischemia oxidants that are initiators of intracellular
cell death signaling pathways may lead to apoptosis [5]. In focal
or global cerebral ischemia, cerebral blood ﬂow is reduced in the
regions of brain that are nourished with oxygen by the occluded
vessels [5]. Damage to cerebral capillaries due to ischemia and
post-ischemic reperfusion results in a progressive alteration in
the permeability of the blood–brain barrier that can subsequently
result in formation of edema and hemorrhagic conversion. In
case of blood–brain barrier permeability, substances such asrticle under the CC BY-NC-ND
Nahid Jivad, Zahra Rabiei/Asian Pac J Trop Biomed 2015; 5(10): 789–795790Na+, water, serum proteins, and blood can enter into the extra-
cellular space of the brain tissue and cause swelling [6–8].
Swelling is deleterious for brain tissue because its effects on
adjacent tissues is also magniﬁed by the ﬁxed volume of the
skull. Swelling of brain tissue induced by brain ischemia and
reperfusion exert a mechanical force on the surrounding shell
of brain tissue, displacing it and causing increasing tissue
pressure within it. When brain tissue pressure exceeds
capillary pressure, capillary inﬂow is compromised, leading to
ischemia and formation of edema [9].
Brain edema is of interesting topics for neurologists who
daily cope with their damaging consequences. During brain
ischemia, the glucose utilization of brain is increased substan-
tially via the reliance of brain on anaerobic glycolysis, so the
brain glucose levels rapidly fall, despite near normal plasma
levels [10].
During brain ischemia and reperfusion a complex cascade of
metabolic events initiated, several of them involve the produc-
tion of nitrogen and oxygen free radicals. These free radicals
mediate much of damages that occur following transient brain
ischemia [11].
During brain ischemia, the reduction in cerebral blood ﬂow
and oxygen utilization initiates a cascade of deleterious
biochemical events. Decrease of oxygen precludes oxidative
phosphorylation and results in anaerobic metabolism [12].
Mitochondrial respiratory chain is the major source for the
production of reactive oxygen species (ROS) and following the
destruction of the mitochondria, necrotic cell death occurs.
Death of endothelial cells causes damage to blood–brain barrier
resulting in cerebral edema [13]. Transcellular ion pump failure
results in the intracellular accumulation of Na+, Ca2+ and
water. The membrane depolarization results in a release of
excitatory neurotransmitters from axon terminals. The
glutamate then activates speciﬁc cell surface receptors
resulting in an inﬂux of Na+ and Ca2+ into postsynaptic
neurons. In neurons, the intracellular calcium induces the
production of nitric oxide (NO) that diffuses to adjacent cells
susceptible to nitric oxide toxicity. When NO combines with
superoxide the proxy nitrites were produced that can cause
lipid peroxidation [14].
Impermeability of the blood–brain barrier is maintained by
tight junctions and basal lamina of microvascular endothelial
cells. During the ﬁrst hours of ischemia, dissolution of the
endothelial basal lamina starts [15].
Recently, focus on plant research has increased worldwide
and most evidences have been collected to determine the
immense potential of medicinal plants. Medical plants have
therapeutic beneﬁts and fewer side effects in comparison with
synthetic drugs. Herbs may provide a source of new com-
pounds including many drugs that are derived from plant
sources.3. Medicinal plants used for the treatment of brain
ischemia and reperfusion
3.1. Artemisia absinthium (A. absinthium)
A. absinthium L. (family: Asteraceae) commonly known as
wormwood is an aromatic herb with ﬁbrous roots. The stems are
straight, growing to 0.8–1.2 m, grooved, branched, and silvery-
green. Ethnopharmacological literature documents the use ofA. absinthium in various countries as an antiseptic, antispas-
modic, febrifuge, cardiac stimulant, for the restoration of
declining mental function and inﬂammation of the liver, and to
improve memory [16].
A. absinthium contains 14 phenolic acids including caffeic
acid, ferulic acid, sinapic acid, p-hydroxyphenol acidic acid,
vanillic acid, salicylic acid, p-coumaric acid that are responsible
for some therapeutic effects. Absinthin and artabsin also have
sesqueterpines lactones, sesqueterpinoids alpha thujone, beta
tujone, chrysanthenyl acetate thujone [17].
A. absinthium contains thujone, a GABAA receptor antago-
nist that can cause epileptic-like convulsions [17].
A. absinthium extracts have both in vitro and in vivo free
radical scavenging activity [18]. The A. absinthium extract
exhibited neuroprotection as it is evident from the reduction of
infarct volume and lipid peroxidation, and restoration of
endogenous antioxidants. Focal cerebral ischemia was induced
by middle cerebral artery occlusion (MCAO) for 90 min
followed by reperfusion for 24 h. It is well documented that
transient focal MCAO causes neurological abnormality. The
focal MCAO-induced increase in lipid peroxidation and
administration of A. absinthium before focal cerebral ischemia
markedly decreased ischemia and reperfusion-induced increase
in the level of thiobarbituric acid reactive substances [18].
A. absinthium contains ﬂavonoids such as quercetin, rutin and
other ﬂavonoid glycosides such as isoquercitrin, quercitin-3-O-
d-glucoside, quercitin-3-O-rhamnoglucoside, isorhamnetin-3-O-
rhamnoglucoside, isorhamnetin-3-glucoside, and phenolic acids
such as chlorogenic, syringic, coumaric, salicylic and vanillic
acids that are probably involved in the mechanism of oxidative
damage [19]. Several researches have shown A. absinthium to
possess potent antioxidant, free radical scavenging and anti-
inﬂammatory activity [20].3.2. Ocimum basilicum (O. basilicum)
O. basilicum L. commonly known as Sweet Basil is native to
Asia, Africa, South America, and the Mediterranean. Basil
grows between 30 and 130 cm tall, with opposite, light green,
silky leaves. The ﬂowers are small and white in color [21]. It has
been used traditionally for treatment of anxiety, headaches,
nerve pain, diabetes, cardiovascular diseases, digestive
disorders, fevers, and migraines, sinusitis, and also as
anticonvulsant, anti-inﬂammatory as well as a variety of
neurodegenerative disorders [22].
The major aroma constituents of O. basilicum were 3, 7-
dimethyl-1, 6-octadien-3-ol (linalool; 3.94 mg/g), 1-methoxy-
4-(2-propenyl) benzene (estragole; 2.03 mg/g), methyl cinna-
mate (1.28 mg/g), 4-allyl-2-methoxyphenol (eugenol; 0.896 mg/
g), and 1, 8-cineole (0.288 mg/g) [22].
The neuroprotective effect of O. basilicum was evaluated
using transient global cerebral ischemia and reperfusion model.
The O. basilicum extract exhibited neuroprotection with reduc-
tion of infarct size and lipid peroxidation as well as restoration of
endogenous antioxidants [23]. The overproduced oxidants are
detoxiﬁed by endogenous antioxidants. Glutathione is
considered as a central component in the antioxidant defenses
of cells. Glutathione acts both to directly detoxify ROS and as
a substrate for various peroxidases [24]. Pre-treatment with
ethyl acetate extract of O. basilicum signiﬁcantly elevated brain
glutathione content [23].
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Ocimum tenuiﬂorum, also known as O. sanctum, holy basil,
is an aromatic plant in the family Lamiaceae which is native to
the Indian and widespread throughout the Southeast Asia. It is
an erect, many branched subshrub, 30–60 cm tall and simple
opposite green or purple leaves. Leaves have petioles, up to 5 cm
long, usually slightly toothed [25].
Traditionally, fresh juice or decoction of O. sanctum leaves is
used to promote health and also in treatment of various disorders
as advocated in Ayurveda. O. sanctum possesses signiﬁcant anti-
inﬂammatory, antioxidant, immunomodulatory and antistress
properties [26].
The occlusion of bilateral common carotid artery for 30 min
followed by 45 min reperfusion caused up-regulation of su-
peroxide dismutase (SOD) activity. The increased SOD activity
is, therefore, an indication that the brain's antioxidant ma-
chinery is activated in response to excessive generation of free
radicals [27].
O. sanctum pretreatment signiﬁcantly prevented the rise in
methane dicarboxylic aldehyde (MDA) levels and up-regulation
of SOD activity. O. sanctum pretreatment attenuates the exces-
sive formation of free radicals to reperfusion injury [26].
3.4. Ginkgo biloba L (G. biloba)
G. biloba is a large tree, reaching a height of 20–35 m. The
tree has an angular and long crown, and is usually deep rooted
and resistant to wind and snow damage.
G. biloba has been used medicinally for thousands of years.
Today, it is one of herbs that more consumed in the United
States. Available evidence supports ginkgo for managing de-
mentia, anxiety, schizophrenia, and cerebral insufﬁciency
(insufﬁcient blood ﬂow to brain). Ginkgo should be used
cautiously in individuals with clotting disorders or taking blood
thinners, or prior to some surgical or dental procedures, due to
reports of bleeding [28].
G. biloba extracts used for medicinal purposes are usually
standardized to contain 24% ginkgo-ﬂavone glycosides and 6%
terpenoids. The terpenoids includes bilobalide and the ginkgo-
lides A, B, C, M, and J that are 20-carbon cage molecules with
six 5-membered rings. Ginkgo extract has the ﬂavonoids that
may contribute to ginkgo's antioxidant and free radical scav-
enging effects [29].
G. biloba extract reduces the cell membrane lipid peroxida-
tion in experimental spinal cord injury similarly to methyl-
prednisolone, reduces bromethalin-induced cerebral lipid
peroxidation and edema. G. biloba extract protect brain neurons
against oxidative stress induced by peroxidation, decrease
neuronal injury following ischemia or electroconvulsive
shock [30].
G. biloba extract inhibits dose-dependently synthesis of nitric
oxide through inhibition of inducible NO synthase [31].
Cerebral edema increases intracranial pressure and exacer-
bates vascular dysfunction impairing cerebral blood ﬂow. The
brain edema in the hippocampal region is increased following
global cerebral ischemia and reperfusion, and in a dose-
dependent way, reduced by pre-treatment with the G. biloba
extract [32].
G. biloba extract pre-treatment reduces nitrite and nitrate
overproduction after transient bilateral carotid occlusion,
thus indicating an inhibitory effect of the extract on nitricoxide formation following transient brain ischemia and reper-
fusion [32].3.5. Gastrodia elata (G. elata)
G. elata is an herb of the Orchidaceae family. The herb has
been used in Traditional Chinese medicine. Medicinally, it is
used for ‘calming the liver’ and for treating headaches, dizzi-
ness, tetanus, and epilepsy. G. elata root has analgesic activity
and inﬂammatory-mediating activities, as well as in vivo and
in vitro inhibitory activity on NO production [33].
G. elata extract inhibited glutamate-induced neuronal
apoptosis of an in vitro system. G. elata extract has protective
effect on the hippocampal neuronal damages following transient
global ischemia in gerbils [34]. Several antioxidants are known to
inhibit the neuronal damage caused by the transient global
ischemia and excitotoxicity [35]. G. elata extract has been
reported to have the free radical scavenging and antioxidant
activity [35].
In another study, G. elata extract pretreatment signiﬁcantly
reduced the cortical and striatum of brain tissue infarct sizes.
G. elata extract provides neuroprotection by preventing brain
damage through the increased expression of genes encoding
antioxidant proteins after transient focal cerebral ischemia and
reperfusion. This may be effective as neuroprotective agents at
the cellular and molecular levels in the brain [36].3.6. Camellia sinensis
Green tea is made from Camellia sinensis leaves that has
undergone minimal oxidation during processing. Green tea
originated in China, but it has become associated with many
cultures throughout Asia and it has recently become relatively
widespread in the West where black tea has been the tradition-
ally consumed tea [37]. Varieties of green tea have been used in
the countries where it is grown. These varieties can differ
substantially due to variable growing conditions, production
processing, and harvesting time [38].
Fresh tea leaf is unusually rich in the ﬂavanol group of
polyphenols known as catechins which may constitute up to
30% of the dry leaf weight. Other polyphenols include ﬂavonols
and their glycosides, and depsides such as chlorogenic acid,
coumarylquinic acid, and one unique to tea, theogallin (3-
galloylquinic acid). Caffeine is present at an average level of
3% along with very small amounts of the other common
methylxanthines, theobromine and theophylline [39].
The hydrogen peroxide level of brain was signiﬁcantly
increased by the ischemia/reperfusion. The 0.5% green tea
extract pretreatment for 3 weeks signiﬁcantly reduced the
increased levels of hydrogen peroxide and also inhibited the
increased production of lipid peroxidation products. Eicosanoid
concentration was signiﬁcantly elevated in the ipsilateral hemi-
sphere by the ischemia/reperfusion compared to contralateral
hemisphere and the elevated eicosanoids concentrations were
signiﬁcantly reduced by the 0.5% green tea extract pretreatment
for 3 weeks [37].3.7. Leaf of Olea europaea (O. europaea)
Olive leaf is the leaf of the olive tree (O. europaea). While
olive oil is well known for its ﬂavor and health beneﬁts, the leaf
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Clinical evidence has been conﬂicting regarding any blood
pressure lowering effect of olive leaf extracts. A liquid extract
made directly from fresh olive leaves gained international
attention when it was shown to have an antioxidant capacity
almost double green tea extract and 400% higher than vitamin
C [41].
Mediterranean diet contains high consumption of olive
products constitute a rich source of polyphenols such as oleur-
opein and its derivatives including hydroxytyrosol [42].
Oleuropein exhibits antioxidative, anti-ischemic, hypolipi-
demic and cardioprotection effects [43].
The pretreatment with olive leaf extract dietary may reduce
infarct volume, brain edema, blood brain permeability, and
neurobehavioral deﬁcit scores in a reliable and reproducible
animal model of stroke followed by reperfusion [44].
The administration of olive leaf extract down regulates the
expression of tumor necrosis factor-b. Therefore, necrosis fac-
tor-b activation and the formation of lipid peroxidation are
inhibited. Oxidative stress via increased production of ROS and
low density lipoprotein oxidation induces inﬂammatory
response; olive phenols with high antioxidant capacity can thus
inhibit low density lipoprotein oxidation and block inﬂammatory
response [45].
Pretreatment with olive leaf extract increased cholesterol,
cholesterol ester, phosphatidylcholine, and cerebroside levels of
brain. Pretreatment with olive leaf extract signiﬁcantly
decreased the brain ceramide levels [46]. Brain ischemia and
reperfusion results in rapid accumulation of free fatty acids
including arachidonic acid and docosahexaenoic acid as a
consequence of the activity of both phospholipase A2 and
phospholipase C. Arachidonic acid has been implicated as a
causative factor to stimulate sphingomyleinase to produce
ceramide. Ceramide induces apoptosis by inhibiting the
mitochondrial electron transport and releasing cytochrome C.
Cytochrome C in turn initiate the apoptotic cellular cell death
cascade by activation of caspase3 [47]. Olive leaf extract
mediated neuroprotection is due to the increase of brain
phosphatidylcholine levels [46].
3.8. Oil of O. europaea
Olive oil is a fat obtained from the olive (the fruit of
O. europaea; family Oleaceae), a traditional tree crop of the
Mediterranean Basin. Olive oil is used throughout the world.
There are many different olive varieties or olives, each with a
particular ﬂavor, texture and shelf-life [48].
The Mediterranean diet, rich in virgin olive oil, improves
the major risk factors for cardiovascular disease, such as the
blood pressure, glucose metabolism, lipoprotein proﬁle, and
antithrombotic proﬁle. Inﬂammation and oxidative stress are
also positively modulated. Some of these effects are attributed
to minor components of virgin olive oil. Therefore, the deﬁ-
nition of the Mediterranean diet should include virgin olive
oil [49].
A key component of this diet is olive oil, which contains
monounsaturated fatty acids and polyphenols, compounds with a
clear antioxidant effect. Tyrosol and hydroxytyrosol are two
such olive oil phenolic compounds; hydroxytyrosol adminis-
tration increased plasma antioxidant capacity and lowered pro-
duction of pro-inﬂammatory and pro-thrombotic mediators in
experimental animals [50].The pretreatment with dietary virgin olive oil reduced
infarct volume, brain edema, blood–brain barrier permeability,
and neurobehavioral deﬁcit scores in animal model of stroke
followed by reperfusion. Dietary virgin olive oil can affect
brain water content and brain water homeostasis by increasing
blood brain permeability integrity. The neuroprotection exerted
by virgin olive oil was mainly seen in the penumbra (cortex).
The lack of protective effects in the subcortical area could be
due to the more severe damage in the subcortical area than in
the cortex. The virgin olive oil mediated neuroprotection is due
to the reduction of post-ischemic infarct volume and brain
edema [51].
Histological analysis indicated that the disruption of the
myelin structure occurs during the ﬁnal period of ischemic tissue
injury and myelin is more resistant to ischemic injury than other
parts of neurons. Sulfatides and galactocerebrosides are the
major lipid constituents of myelin sheath. Concentrations of
cerebrosides and sulfatides are decreased during ischemia [52].
However, virgin olive oil consumption at 0.75 mL/kg/day can
increase brain cerebroside levels [53].3.9. Lavandula ofﬁcinalis (L. ofﬁcinalis)
L. ofﬁcinalis is a genus of 39 known species of ﬂowering
plants in the mint family, Lamiaceae. Flowers are borne in
whorls, held on spikes rising above the foliage. Some species
produce colored bracts at the apices. The ﬂowers may be blue,
violet or lilac in the wild species, occasionally blackish purple or
yellowish [54].
L. ofﬁcinalis is well known as a powerful aromatic and me-
dicinal herb. The plant is used in traditional and folk medicines
of all over the world for the treatment of several gastrointestinal,
nervous and rheumatic disorders [55].
Lavender is comprised of over 100 constituents, among
which the primary components are linalool and linalyl acetate,
a-pinene, limonene, 1, 8-cineole, cis-and trans-ocimene, 3-
octanone, camphor, caryophyllene, terpinen-4-ol, and ﬂavo-
noids [56].
The pretreatment of rats with 200 mg of lavender extract
caused a signiﬁcant decrease in the permeability of the blood–
brain barrier. Lavender extract reduced serum and brain MDA
levels, which proved lavender extract may increase the antiox-
idant capacity in brain and serum [57].
The treatment with lavender oil signiﬁcantly decreased
neurological deﬁcit scores, infarct size, the levels of MDA,
carbonyl and ROS, and decreased neuronal damage, upregu-
lated super oxide dismutase, catalase, glutathione peroxidase
activities and glutathione/oxidized glutathione ratio. The neu-
roprotective effects of lavender oil against cerebral ischemia/
reperfusion injury may be attributed to its antioxidant
effects [58].3.10. Baicalin and jasminoidin
Baicalin and jasminoidin are two major compounds extracted
from Chinese herbs. Baicalin is extracted from the dried root of
Scutellaria baicalensis, but jasminoidin is extracted from the
dried fruit of Gardenia jasminoides Ellis [59]. The baicalin and
jasminoidin could markedly decrease the infarction area in the
rat brain [60]. In animal model of stroke, baicalin could
decrease the lipid peroxidation and the releases of glutamate
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interfere with its activations to N-methyl-D-aspartate receptor
and nitric oxide synthase [61].
Jasminoidin could reduce the expression of monocyte che-
moattractant protein-1 in ischemic brain in rats. Baicalin and
jasminoidin attenuate the infarction volume in rat brains sub-
jected to focal ischemia. The combined treatment of baicalin and
jasminoidin resulted in signiﬁcant decrease in infarction volume
compared with that treated with baicalin or jasminoidin indi-
vidually [60].
Baicalin markedly increased brain-derived neurotrophic fac-
tor (BDNF) mRNA expression in the hippocampus in rats un-
dergoing focal cerebral ischemia–reperfusion injury; both
baicalin and jasminoidin decreased caspase-3 mRNA expression
[60]. BDNF and caspase-3 represent ameliorated and deteriorated
orientations in the course of cerebral ischemic damage, respec-
tively. BDNF can protect cell from ischemia, and inhibit cell
apoptosis [62].
4. Conclusion
Medicinal plants play an important role in the treatment of
many incurable diseases like neurological disease [63–71]. Since
brain ischemia and reperfusion is a complex progressive injury
involving a series of mechanisms such as cell survival and
apoptosis, ROS accumulation, Ca2+ overload, inﬂammation,
microglia aggregation, etc., it is difﬁcult to describe the
mechanisms of protective agents against ischemia and
reperfusion. In conclusion, development of protective agents
from traditional herb medicine is a promising direction in the
treatment of ischemic cerebral injury and related
neurodegenerative diseases. In the future, more attention
should be paid to natural compounds that can transverse the
blood–brain barrier and have wide therapeutic time windows,
clear pharmacological targets and fewer side effects.
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